Not logged in...
About USC Norris
FAQ - Trials
Contact Us - Trials
Support USC Norris
» Contact Us
If you are a patient, please contact
Keck Medical Center of USC
(St Joseph only) A Phase II Trial of Azacitidine (NSC-102816) Plus Gemtuzumab Ozogamicin (NSC-720568) as Induction and Post-Remission Therapy in Patients of Age 60 and Older with Previously Untreated Non-M3 Acute Myeloid Leukemia.
Closed to Accrual with Ongoing Follow-up
Defintions of terms and FAQ about clinical trials.
Raul Mena, M.D.
Other Trial Staff:
Veronica Hudson, D.M.
to see study documents.
Click here to see trial eligibility criteria and further details at SWOG.org
For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or
To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.